Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006499
Filing Date
2024-11-14
Accepted
2024-11-14 06:44:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 UROGEN PHARMA LTD. p24-3262sc13ga.htm SC 13G/A 64443
  Complete submission text file 0000902664-24-006499.txt   66076
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89992 | Film No.: 241457000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)